DMRF Canada and Allergan Canada Launch Dystonia Clinical Fellowship

DMRF Canada and Allergan Canada Launch Dystonia Clinical Fellowship

English Français

DMRF Canada is pleased to offer a one-year clinical fellowship to support the training of exceptionally qualified physicians in preparation for their clinical career in movement disorders with a focus on dystonia and a special competence in use of botulinum toxins. In 2017, this program will support fellows through a grant from Allergan.

The goal of this program is to encourage growth and support of the field of movement disorders in Canada, with a focus on dystonia to support dystonia patients. Canadian citizenship is not a requirement; however, in the selection, preference will be given to candidates who express the intent to practice in Canada.

The fellowship should focus on training in both the clinical evaluation and care of patients with movement disorders, with a focus on dystonia.  The training must be patient-oriented and include hands-on experience in clinics as well as participation in professional meetings and workshops. The fellowship will be held at an Institution where the applicant is registered in a postgraduate training program, and where the proposed supervisor holds a faculty appointment.

Eligibility

The fellowships will only be awarded to individuals who hold the equivalent of the Royal College of Physicians and Surgeons College in Neurology and are qualified to practice in the movement disorder field in Canada. In addition, applicants must be involved with institutions that have established training programs with appropriate resources to provide both clinical and research training in dystonia, including the use of botulinum toxin type A and type B approved for use in Canada. 

The applicant must have a mentor at the institution with clinical expertise in dystonia, who will develop a mentorship plan for the fellow. To become eligible, an institution must provide information on the training environment, program curriculum, available resources and the expected amount of exposure to patients with dystonia. 

Review and Selection:

All applications would be reviewed by the executive members of the Canadian Movement Disorder Group. Selection criteria will include the following:

  • Review of the applicant;
  • Review of the applicant’s mentor;
  • Review of the outlined mentorship plan;
  • Relevance to the field of movement disorders with a specific focus on dystonia.

Applications for the fellowships, which are expected to start July 2018 should be submitted electronically to the DMRF Canada by December 15, 2017.  

Please see attachment below for additional details and an application form.

DMRF Canada Allergan Clinical Fellowship Application Form

DMRF Canada Clinical Fellowship Terms and Conditions 2018 - For Signature